HIV-infected youths transitioning from pediatric to adult outpatient care in a teaching tertiary care hospital in Sao Paulo city, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER BRAZIL
Citação
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.23, n.5, p.291-297, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: HIV-infected children surviving until adulthood have been transitioning to adult outpatient health care service in Brazil since the late 2000's. Deterioration of clinical condition is expected during this period, as reported among youths with non-communicable chronic diseases. Despite their young age, they are long-term hosts of the virus, have prolonged exposure to antiretroviral therapy and have suffered from the social determinants and stigma of HIV infection since early childhood. Objectives: This study aimed to (1) describe demographic and clinical characteristics at the first appointment at adult care service following pediatric care of a cohort of Brazilian youths living with HIV since childhood; and (2) retrospectively address adherence and clinical variables in the last two years of pediatric follow-up. Methods: Descriptive study. Results: 41 consecutive patients referred to adult outpatient care from a pediatric HIV unit were enrolled, median age 19 years, and median lifetime CD4+ nadir 117 cell/mm(3); 89% reported previous AIDS-defining conditions. At first laboratory assessment in adult care, only 46% had undetectable (<400 copies/ml) HIV viral load and the median CD4+ count was 250 cell/mm(3). Conclusion: Youths living with HIV at the transition from pediatric to adult care had poor treatment adherence, low lifetime CD4+ cell nadir, low CD4 cell count and detectable HIV viral load. Health care providers should closely monitor these adolescents in a youth friendly environment, prepared for open communication about all aspects of their health. (C) 2019 Sociedade Brasileira de Infectologia.
Palavras-chave
Adolescent, Young adult, Pediatric HIV, Transition-to-care, Adult care
Referências
  1. Acree ME, 2017, PEDIATR ANN, V46, pE198, DOI 10.3928/19382359-20170424-02
  2. Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009
  3. Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579
  4. [Anonymous], 1994, MMWR Recomm Rep, V43, P1
  5. Badell Martina L, 2013, Infect Dis Obstet Gynecol, V2013, P301763, DOI 10.1155/2013/301763
  6. Barlow-Mosha L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18600
  7. Blazquez D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0853-8
  8. Buchanan AL, 2012, PEDIATRICS, V129, pE1244, DOI 10.1542/peds.2011-1740
  9. Byrne L, 2014, J INT AIDS SOC, V17, P130, DOI 10.7448/IAS.17.4.19693
  10. Campbell F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009794.pub2
  11. Casseb J, 2012, REV INST MED TROP SP, V54, P257, DOI 10.1590/S0036-46652012000500004
  12. Coelho L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098666
  13. Cohen S, 2016, NEUROLOGY, V86, P19, DOI 10.1212/WNL.0000000000002209
  14. Cordova E, 2015, ENFERM INFEC MICR CL, V33, P134, DOI 10.1016/j.eimc.2014.05.005
  15. de Mulder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052155
  16. de Paula CC, 2011, REV BRAS ENFERM, V64, P658, DOI 10.1590/S0034-71672011000400005
  17. Favarato G, 2017, J INT AIDS SOC, V20, P75
  18. Fortuny C, 2015, PEDIATR INFECT DIS J, V34, pS36, DOI 10.1097/INF.0000000000000663
  19. Judd A, 2017, HIV MED, V18, P171, DOI 10.1111/hiv.12411
  20. Kacanek D, 2015, AIDS, V29, P1227, DOI 10.1097/QAD.0000000000000697
  21. Kakkar F, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0644-4
  22. Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316
  23. Lipshultz SE, 2013, JAMA PEDIATR, V167, P520, DOI 10.1001/jamapediatrics.2013.1206
  24. Machado DM, 2016, BRAZ J INFECT DIS, V20, P229, DOI 10.1016/j.bjid.2015.12.009
  25. Ministerio da Sande Secretaria de Acoes Basicas de Sande, 1987, REC PREV CONTR INF P
  26. Ministerio da Sande Secretaria de Politicas de Sande, 2001, COORD NAC DST AIDS G
  27. Ministerio da Sande Secretaria de Vigilancia em n Sande Programa Nacional de DST e AIDS, 2009, REC TER ANT CRIANC I
  28. Mirani G, 2015, CLIN INFECT DIS, V61, P1850, DOI 10.1093/cid/civ687
  29. Nichols SL, 2016, PEDIATR INFECT DIS J, V35, P649, DOI 10.1097/INF.0000000000001131
  30. Rudy BJ, 2010, AIDS PATIENT CARE ST, V24, P97, DOI 10.1089/apc.2009.0198
  31. Ryscavage P, 2016, AIDS CARE, V28, P561, DOI 10.1080/09540121.2015.1131967
  32. Cruz MLS, 2015, AIDS CARE, V27, P6, DOI 10.1080/09540121.2014.940270
  33. Schtscherbyna A, 2012, INT J INFECT DIS, V16, pE872, DOI 10.1016/j.ijid.2012.07.019
  34. Sheth SS, 2015, AIDS CARE, V27, P350, DOI 10.1080/09540121.2014.998610
  35. Slogrove A, 2017, J INT AIDS SOC, V20, P9
  36. Tanaka Luana Fiengo, 2015, Rev Paul Pediatr, V33, P327, DOI 10.1016/j.rpped.2014.12.003
  37. Tanaka LF, 2015, J PEDIAT-BRAZIL, V91, P152, DOI 10.1016/j.jped.2014.06.007
  38. Van der Linden D, 2013, J PEDIATR INFECT DIS, V2, P382, DOI 10.1093/jpids/pis106
  39. Westling K, 2016, INFECT DIS-NOR, V48, P449, DOI 10.3109/23744235.2016.1143964